|
1
|
Sinha MK, Sturis J, Ohannesian J, Magosin
S, Stephens T, Heiman ML, Polonsky KS and Caro JF: Ultradian
oscillations of leptin secretion in humans. Biochem Biophys Res
Commun. 228:733–738. 1996. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Maffei M, Halaas J, Ravussin E, Pratley
RE, Lee GH, Zhang Y, Fei H, Kim S, Lallone R, Ranganathan S, et al:
Leptin levels in human and rodent: Measurement of plasma leptin and
ob RNA in obese and weight-reduced subjects. Nat Med. 1:1155–1161.
1995. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Zhang J and Wang N: Leptin in chronic
kidney disease: A link between hematopoiesis, bone metabolism, and
nutrition. Int Urol Nephrol. 46:1169–1174. 2014. View Article : Google Scholar
|
|
4
|
Reseland JE, Syversen U, Bakke I, Qvigstad
G, Eide LG, Hjertner O, Gordeladze JO and Drevon CA: Leptin is
expressed in and secreted from primary cultures of human
osteoblasts and promotes bone mineralization. J Bone Miner Res.
16:1426–1433. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Taichman RS and Hauschka PV: Effects of
interleukin-1 beta and tumor necrosis factor-alpha on osteoblastic
expression of osteocalcin and mineralized extracellular matrix in
vitro. Inflammation. 16:587–601. 1992. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Laharrague P, Larrouy D, Fontanilles AM,
Truel N, Campfield A, Tenenbaum R, Galitzky J, Corberand JX,
Pénicaud L and Casteilla L: High expression of leptin by human bone
marrow adipocytes in primary culture. FASEB J. 12:747–752.
1998.PubMed/NCBI
|
|
7
|
Zhang Y, Proenca R, Maffei M, Barone M,
Leopold L and Friedman JM: Positional cloning of the mouse obese
gene and its human homologue. Nature. 372:425–432. 1994. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Sebastién-Ochoa A, Fernández-Garcia D,
Reyes-García R, Mezquita-Raya P, Rozas-Moreno P, Alonso-Garcia G
and Muñoz-Torres M: Adiponectin and leptin serum levels in
osteoporotic postmenopausal women treated with raloxifene or
alendronate. Menopause. 19:172–177. 2012. View Article : Google Scholar
|
|
9
|
Lajeunesse D, Pelletier JP and
Martel-Pelletier J: Osteoarthritis: A metabolic disease induced by
local abnormal leptin activity? Curr Rheumatol Rep. 7:79–81. 2005.
View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Lee SW, Park MC, Park YB and Lee SK:
Measurement of the serum leptin level could assist disease activity
monitoring in rheumatoid arthritis. Rheumatol Int. 27:537–540.
2007. View Article : Google Scholar
|
|
11
|
Wu YP, Chen WS, Xu SJ and Zhang N:
Osteoporosis as a potential contributor to the bone metastases. Med
Hypotheses. 75:514–516. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Ducy P, Amling M, Takeda S, Priemel M,
Schilling AF, Beil FT, Shen J, Vinson C, Rueger JM and Karsenty G:
Leptin inhibits bone formation through a hypothalamic relay: A
central control of bone mass. Cell. 100:197–207. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Bartell SM, Rayalam S, Ambati S, Gaddam
DR, Hartzell DL, Hamrick M, She JX, Della-Fera MA and Baile CA:
Central (ICV) leptin injection increases bone formation, bone
mineral density, muscle mass, serum IGF-1, and the expression of
osteogenic genes in leptin-deficient ob/ob mice. J Bone Miner Res.
26:1710–1720. 2011. View
Article : Google Scholar : PubMed/NCBI
|
|
14
|
Neve A, Corrado A and Cantatore FP:
Osteoblast physiology in normal and pathological conditions. Cell
Tissue Res. 343:289–302. 2011. View Article : Google Scholar
|
|
15
|
Takeda S, Elefteriou F, Levasseur R, Liu
X, Zhao L, Parker KL, Armstrong D, Ducy P and Karsenty G: Leptin
regulates bone formation via the sympathetic nervous system. Cell.
111:305–17. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Sawada N, Taketani Y, Amizuka N, Ichikawa
M, Ogawa C, Nomoto K, Nashiki K, Sato T, Arai H, Isshiki M, et al:
Caveolin-1 in extracellular matrix vesicles secreted from
osteoblasts. Bone. 41:52–58. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Zeidan A, Purdham DM, Rajapurohitam V,
Javadov S, Chakrabarti S and Karmazyn M: Leptin induces vascular
smooth muscle cell hypertrophy through angiotensin II- and
endothelin-1-dependent mechanisms and mediates stretch-induced
hypertrophy. J Pharmacol Exp Ther. 315:1075–1084. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Baker N, Zhang G, You Y and Tuan RS:
Caveolin-1 regulates proliferation and osteogenic differentiation
of human mesenchymal stem cells. J Cell Biochem. 113:3773–3787.
2012. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Solomon KR, Danciu TE, Adolphson LD, Hecht
LE and Hauschka PV: Caveolin-enriched membrane signaling complexes
in human and murine osteoblasts. J Bone Miner Res. 15:2380–2390.
2000. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Hens JR, Wilson KM, Dann P, Chen X,
Horowitz MC and Wysolmerski JJ: TOPGAL mice show that the canonical
Wnt signaling pathway is active during bone development and growth
and is activated by mechanical loading in vitro. J Bone Miner Res.
20:1103–1113. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Forbes A, Wadehra M, Mareninov S, Morales
S, Shimazaki K, Gordon LK and Braun J: The tetraspan protein EMP2
regulates expression of caveolin-1. J Biol Chem. 282:26542–26551.
2007. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Basu Roy UK, Henkhaus RS, Loupakis F,
Cremolini C, Gerner EW and Ignatenko NA: Caveolin-1 is a novel
regulator of K-RAS-dependent migration in colon carcinogenesis. Int
J Cancer. 133:43–57. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-timequantitative PCR and
the 2(-Delta Delta C(T)) Method. Methods. 25:402–408. 2001.
View Article : Google Scholar
|
|
24
|
Liu GY, Liang QH, Cui RR, Liu Y, Wu SS,
Shan PF, Yuan LQ and Liao EY: Leptin promotes the osteoblastic
differentiation of vascular smooth muscle cells from female mice by
increasing RANKL expression. Endocrinology. 155:558–567. 2014.
View Article : Google Scholar
|
|
25
|
Li Z, Shen J, Wu WK, Yu X, Liang J, Qiu G
and Liu J: Leptin induces cyclin D1 expression and proliferation of
human nucleus pulposus cells via JAK/STAT, PI3K/Akt and MEK/ERK
pathways. PLoS One. 7:e531762012. View Article : Google Scholar
|
|
26
|
Beaulieu A, Poncin G, Belaid-Choucair Z,
Humblet C, Bogdanovic G, Lognay G, Boniver J and Defresne MP:
Leptin reverts pro-apoptotic and antiproliferative effects of
α-linolenic acids in BCR-ABL positive leukemic cells: Involvement
of PI3K pathway. PLoS One. 6:e256512011. View Article : Google Scholar
|
|
27
|
Lloyd JT, Alley DE, Hawkes WG, Hochberg
MC, Waldstein SR and Orwig DL: Body mass index is positively
associated with bone mineral density in US older adults. Arch
Osteoporos. 9:1752014. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Frankenberry KA, Somasundar P, McFadden DW
and Vona-Davis LC: Leptin induces cell migration and the expression
of growth factors in human prostate cancer cells. Am J Surg.
188:560–565. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Tsuchiya T, Shimizu H, Horie T and Mori M:
Expression of leptin receptor in lung: Leptin as a growth factor.
Eur J Pharmacol. 365:273–279. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Gordeladze JO, Drevon CA, Syversen U and
Reseland JE: Leptin stimulates human osteoblastic cell
proliferation, de novo collagen synthesis, and mineralization:
Impact on differentiation markers, apoptosis, and osteoclastic
signaling. J Cell Biochem. 85:825–836. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Lee YJ, Park JH, Ju SK, You KH, Ko JS and
Kim HM: Leptin receptor isoform expression in rat osteoblasts and
their functional analysis. FEBS Lett. 528:43–47. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Zhang J, Lazarenko OP, Blackburn ML,
Badger TM, Ronis MJ and Chen JR: Soy protein isolate down-regulates
caveolin-1 expression to suppress osteoblastic cell senescence
pathways. FASEB J. 28:3134–3145. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Singh P, Peterson TE, Sert-Kuniyoshi FH,
Jensen MD and Somers VK: Leptin upregulates caveolin-1 expression:
Implications for development of atherosclerosis. Atherosclerosis.
217:499–502. 2011. View Article : Google Scholar
|
|
34
|
Jasmin JF, Mercier I, Sotgia F and Lisanti
MP: SOCS proteins and caveolin-1 as negative regulators of
endocrine signaling. Trends Endocrinol Metab. 17:150–158. 2006.
View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Razani B, Woodman SE and Lisanti MP:
Caveolae: From cell biology to animal physiology. Pharmacol Rev.
54:431–467. 2002. View Article : Google Scholar : PubMed/NCBI
|
